Phosphoglycerate Mutase 1 Coordinates Glycolysis and Biosynthesis to Promote Tumor Growth
Taro Hitosugi,Lu Zhou,Shannon Elf,Jun Fan,Hee-Bum Kang,Jae Ho Seo,Changliang Shan,Qing Dai,Liang Zhang,Jianxin Xie,Ting-Lei Gu,Peng Jin,Masa Aleckovic,Gary LeRoy,Yibin Kang,Jessica A. Sudderth,Ralph J. DeBerardinis,Chi-Hao Luan,Georgia Z. Chen,Susan Muller,Dong M. Shin,Taofeek K. Owonikoko,Sagar Lonial,Martha L. Arellano,Hanna J. Khoury,Fadlo R. Khuri,Benjamin H. Lee,Keqiang Ye,Titus J. Boggon,Sumin Kang,Chuan He,Jing Chen
DOI: https://doi.org/10.1016/j.ccr.2012.09.020
IF: 50.3
2012-01-01
Cancer Cell
Abstract:It is unclear how cancer cells coordinate glycolysis and biosynthesis to support rapidly growing tumors. We found that the glycolytic enzyme phosphoglycerate mutase 1 (PGAM1), commonly upregulated in human cancers due to loss of TP53, contributes to biosynthesis regulation in part by controlling intracellular levels of its substrate, 3-phosphoglycerate (3-PG), and product, 2-phosphoglycerate (2-PG). 3-PG binds to and inhibits 6-phosphogluconate dehydrogenase in the oxidative pentose phosphate pathway (PPP), while 2-PG activates 3-phosphoglycerate dehydrogenase to provide feedback control of 3-PG levels. Inhibition of PGAM1 by shRNA or a small molecule inhibitor PGMI-004A results in increased 3-PG and decreased 2-PG levels in cancer cells, leading to significantly decreased glycolysis, PPP flux and biosynthesis, as well as attenuated cell proliferation and tumor growth.